Body

“Pharmaceutical companies judge our clinical trial work by the quality of the results and the speed and cost effectiveness with which those results are delivered,” says Graham Ramsay, a member of Atrium’s board of directors. “We’ll be able to deliver high-quality results to our pharmaceutical clients more rapidly and with reduced paperwork, while making certain that the innovative projects we choose to support and implement are the ones that will most greatly benefit those who turn to us for their health care needs.”
…
Want to continue?
Log in or create a FREE account.
By logging in you agree to receive communication from Quality Digest.
Privacy Policy.
Add new comment